Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000932471-18-003057
Filing Date
2018-02-08
Accepted
2018-02-08 15:05:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 interceptpharmaceuticalsinc.htm SC 13G 43908
  Complete submission text file 0000932471-18-003057.txt   45407
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

IRS No.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Subject) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87033 | Film No.: 18585328
SIC: 2834 Pharmaceutical Preparations